Promisia Healthcare Limited (NZE:PHL)
0.7100
-0.0100 (-1.39%)
Sep 3, 2026, 9:59 AM NZST
Promisia Healthcare Ratios and Metrics
Market cap in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 38 | 25 | 17 | 21 | 21 | 43 | |
Market Cap Growth | 64.76% | 42.77% | -19.17% | 0.90% | -50.00% | 18.32% |
Enterprise Value | 80 | 71 | 70 | 52 | 49 | 69 |
Last Close Price | 0.72 | 0.47 | 0.33 | 0.50 | 0.50 | 1.00 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 3.35 | 1.92 | 2.54 | 13.14 | 30.76 | 21.00 |
PS Ratio | 0.95 | 0.62 | 0.56 | 0.98 | 0.91 | 2.24 |
PB Ratio | 0.69 | 0.45 | 0.44 | 0.86 | 1.06 | 2.29 |
P/TBV Ratio | 0.69 | 0.45 | 0.44 | 0.86 | 1.06 | 2.29 |
P/FCF Ratio | 6.56 | 4.25 | 5.57 | 3.00 | - | 9.89 |
P/OCF Ratio | 6.01 | 3.90 | 5.10 | 2.87 | 3.01 | 8.89 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.99 | 1.77 | 2.26 | 2.35 | 2.09 | 3.61 |
EV/EBITDA Ratio | 12.48 | 11.20 | 25.12 | 26.75 | 15.45 | 23.95 |
EV/EBIT Ratio | 13.58 | 12.10 | 29.43 | 45.82 | 21.01 | 25.19 |
EV/FCF Ratio | 13.68 | 12.20 | 22.48 | 7.19 | - | 15.92 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.75 | 0.75 | 1.19 | 1.17 | 1.54 | 0.92 |
Debt / EBITDA Ratio | 6.51 | 6.51 | 16.73 | 15.13 | 9.75 | 4.86 |
Debt / FCF Ratio | 7.14 | 7.14 | 14.97 | 4.07 | - | 3.98 |
Net Debt / Equity Ratio | 0.75 | 0.75 | 1.19 | 1.17 | 1.43 | 0.79 |
Net Debt / EBITDA Ratio | 6.55 | 6.55 | 16.68 | 15.07 | 9.10 | 5.15 |
Net Debt / FCF Ratio | 7.13 | 7.13 | 14.93 | 4.05 | -4.23 | 3.42 |
Asset Turnover | 0.22 | 0.22 | 0.24 | 0.28 | 0.38 | 0.35 |
Quick Ratio | 0.05 | 0.05 | 0.07 | 0.04 | 0.15 | 0.45 |
Current Ratio | 0.07 | 0.07 | 0.17 | 0.06 | 0.19 | 0.65 |
Return on Equity (ROE) | 27.36% | 27.36% | 20.50% | 4.39% | 3.58% | 11.45% |
Return on Assets (ROA) | 1.98% | 1.98% | 1.16% | 0.90% | 2.36% | 3.10% |
Return on Invested Capital (ROIC) | 5.63% | 5.96% | 3.36% | 0.73% | 5.66% | 7.12% |
Return on Capital Employed (ROCE) | 3.50% | 3.50% | 1.60% | 2.20% | 4.60% | 6.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 33.83% | 52.14% | 39.38% | 7.61% | 3.25% | 4.76% |
FCF Yield | 15.25% | 23.51% | 17.97% | 33.36% | -32.00% | 10.12% |
Buyback Yield / Dilution | -10.14% | -10.14% | -30.93% | -0.36% | -0.54% | -199.85% |